All Pharma News
Roivant launches $1.5 billion share buyback program

Roivant launches $1.5 billion share buyback program
PRESS RELEASE
02 Apr 2024
Share Share
Sumitomo Pharma Announces Availability of ORGOVYX® (relugolix) in Canada

Sumitomo Pharma Announces Availability of ORGOVYX® (relugolix) in Canada
PR NEWSWIRE
12 Mar 2024
Share Share
Sumitomo Pharma Presents Encouraging New Data on DSP-5336 Clinical Activity

Sumitomo Pharma Presents Encouraging New Data on DSP-5336 Clinical Activity
PR NEWSWIRE
11 Dec 2023
Share Share
Actor becomes first ‘Gemtesa Go-Getter’ in Sumitomo OAB campaign

Actor becomes first ‘Gemtesa Go-Getter’ in Sumitomo OAB campaign
Nick Paul Taylor FIERCE PHARMA
29 Nov 2023
Share Share
Sumitomo and Actress Holly Robinson Peete Extend Time To Go™ Campaign

Sumitomo and Actress Holly Robinson Peete Extend Time To Go™ Campaign
PR NEWSWIRE
21 Nov 2023
Share Share
Sumitomo to Present Clinical Data Evaluating TP-3654 and DSP-5336

Sumitomo to Present Clinical Data Evaluating TP-3654 and DSP-5336
PR NEWSWIRE
03 Nov 2023
Share Share
EC Approves the Commercialisation of RYEQO® for Endometriosis

EC Approves the Commercialisation of RYEQO® for Endometriosis
PR NEWSWIRE
02 Nov 2023
Share Share
Kyorin and Sumitomo to introduce drug for overactive bladder in Taiwan & other Asian countries

Kyorin and Sumitomo to introduce drug for overactive bladder in Taiwan & other Asian countries
PRESS RELEASE
06 Mar 2023
Share Share
Jazz doubles down on sleep disorders, putting down $50M cash on Sumitomo drug

Jazz doubles down on sleep disorders, putting down $50M cash on Sumitomo drug
A. Tong ENDPTS
06 May 2022
Share Share
Sumitomo Pharma takes license to CRISPR/Cas9 patent portfolio from ERS Genomics

Sumitomo Pharma takes license to CRISPR/Cas9 patent portfolio from ERS Genomics
BIOSPECTRUMASIA
28 Apr 2022
Share Share